Literature DB >> 1309988

Management strategies in resection for hilar cholangiocarcinoma.

H Bismuth1, R Nakache, T Diamond.   

Abstract

Between 1960 and 1990, resection was performed in 23 of 122 patients who underwent surgical treatment for hilar cholangiocarcinoma. Local excision of the lesion alone was performed in 10 cases (43%). Hepatic resection for tumor extending to the secondary bile ducts or hepatic parenchyma was performed in 13 cases (57%): extended right hepatectomy (3), right hepatectomy (1), extended left hepatectomy (6), left hepatectomy (2), and left lobectectomy (1). In three other cases, resection by total hepatectomy and liver transplantation was performed, but these were not included in the analysis of results for resection. Significant operative complications occurred in only two cases (8.7%), and the operative mortality rate was zero. In four cases, complete excision of the tumor could not be achieved macroscopically (macroscopic curative resection rate 19/122; 15.6%). In nine cases, the margins of the resected specimens were free from tumor on histologic examination (microscopic curative resection rate, 9/122; 7.4%). In 10 cases, the resection margins were found to contain tumor on histologic examination. The overall survival rate was 87% at 1 year, 63% at 2 years, and 25% at 3 years (median survival, 24 months). The survival and freedom from recurrence rates for patients with free resection margins was superior to that for patients with involved resection margins or residual macroscopic disease. A potentially curative resection, with histologically negative margins and no recurrence to date, was achieved in seven patients using the following procedures: local excision for two type I lesions; left hepatectomy plus excision of segment 1 for two type IIIb lesions and one type IV lesion; right hepatectomy and right hepatectomy plus excision of segment 1 for two type IIIa lesions. These results indicate that improved survival in hilar cholangiocarcinoma can be achieved by resection, with minimal morbidity and zero mortality rates, if histologically free resection margins are obtained. To achieve this, we recommend the following procedures for each type of lesion, based on our experience and on anatomic considerations: local excision for type I; local excision plus resection of segment 1 for type II; local excision, resection of segment 1, and right or left hepatectomy for types IIIa and b; hepatectomy plus liver transplantation for type IV.

Entities:  

Mesh:

Year:  1992        PMID: 1309988      PMCID: PMC1242367          DOI: 10.1097/00000658-199201000-00005

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  24 in total

1.  ADENOCARCINOMA OF THE HEPATIC DUCT AT ITS BIFURCATION WITHIN THE PORTA HEPATIS. AN UNUSUAL TUMOR WITH DISTINCTIVE CLINICAL AND PATHOLOGICAL FEATURES.

Authors:  G KLATSKIN
Journal:  Am J Med       Date:  1965-02       Impact factor: 4.965

2.  Management of proximal cholangiocarcinomas by surgical resection and radiotherapy.

Authors:  J L Cameron; H A Pitt; M J Zinner; S L Kaufman; J Coleman
Journal:  Am J Surg       Date:  1990-01       Impact factor: 2.565

3.  Extended right hepatic lobectomy, left hepatic lobectomy, and skeletonization resection for proximal bile duct cancer.

Authors:  C W Pinson; R L Rossi
Journal:  World J Surg       Date:  1988-02       Impact factor: 3.352

4.  Resection or palliation: priority of surgery in the treatment of hilar cancer.

Authors:  H Bismuth; D Castaing; O Traynor
Journal:  World J Surg       Date:  1988-02       Impact factor: 3.352

5.  Newer techniques in the diagnosis and treatment of proximal bile duct carcinoma--an analysis of 41 consecutive patients.

Authors:  P G Wheeler; J L Dawson; H Nunnerley; D Brinkley; J Laws; R Williams
Journal:  Q J Med       Date:  1981

6.  Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus.

Authors:  Y Nimura; N Hayakawa; J Kamiya; S Kondo; S Shionoya
Journal:  World J Surg       Date:  1990 Jul-Aug       Impact factor: 3.352

7.  Carcinoma of the hepatic hilus. Surgical management and the case for resection.

Authors:  B Launois; J P Campion; P Brissot; M Gosselin
Journal:  Ann Surg       Date:  1979-08       Impact factor: 12.969

8.  Surgical management of 552 carcinomas of the extrahepatic bile ducts (gallbladder and periampullary tumors excluded). Results of the French Surgical Association Survey.

Authors:  R Reding; J L Buard; G Lebeau; B Launois
Journal:  Ann Surg       Date:  1991-03       Impact factor: 12.969

9.  Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver.

Authors:  H Bismuth; M B Corlette
Journal:  Surg Gynecol Obstet       Date:  1975-02

10.  Proximal bile duct cancer. Quality of survival.

Authors:  E C Lai; R K Tompkins; L L Mann; J J Roslyn
Journal:  Ann Surg       Date:  1987-02       Impact factor: 12.969

View more
  191 in total

1.  Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience.

Authors:  J I Tsao; Y Nimura; J Kamiya; N Hayakawa; S Kondo; M Nagino; M Miyachi; M Kanai; K Uesaka; K Oda; R L Rossi; J W Braasch; J M Dugan
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

2.  Changing trends of surgical treatment of hilar bile duct cancer: clinical and experimental perspectives.

Authors:  Zhi-Qiang Huang; Ning-Xin Zhou; Da-Dong Wang; Jian-Guo Lu; Ming-Yi Chen
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

Review 3.  Photodynamic therapy in the biliary tract.

Authors:  M Ortner
Journal:  Curr Gastroenterol Rep       Date:  2001-04

Review 4.  Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer.

Authors:  J R A Skipworth; S W M Olde Damink; C Imber; J Bridgewater; S P Pereira; M Malagó
Journal:  Aliment Pharmacol Ther       Date:  2011-09-20       Impact factor: 8.171

Review 5.  [Resection of Klatskin tumors].

Authors:  D Seehofer; C Kamphues; P Neuhaus
Journal:  Chirurg       Date:  2012-03       Impact factor: 0.955

Review 6.  Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? A systematic review.

Authors:  Fei Liu; Ya Li; Yonggang Wei; Bo Li
Journal:  Dig Dis Sci       Date:  2010-07-16       Impact factor: 3.199

7.  Distal extrahepatic cholangiocarcinoma presenting as cholangitis.

Authors:  Maximilian Lee; Subhas Banerjee; Mitchell C Posner; Christine A Cartwright
Journal:  Dig Dis Sci       Date:  2010-05-26       Impact factor: 3.199

8.  Preoperative biliary drainage in perihilar cholangiocarcinoma: identifying patients who require percutaneous drainage after failed endoscopic drainage.

Authors:  Jimme K Wiggers; Bas Groot Koerkamp; Robert J Coelen; Erik A Rauws; Mark A Schattner; C Yung Nio; Karen T Brown; Mithat Gonen; Susan van Dieren; Krijn P van Lienden; Peter J Allen; Marc G H Besselink; Olivier R C Busch; Michael I D'Angelica; Robert P DeMatteo; Dirk J Gouma; T Peter Kingham; William R Jarnagin; Thomas M van Gulik
Journal:  Endoscopy       Date:  2015-09-18       Impact factor: 10.093

9.  Spiegel's lobe bile ducts often drain into the right hepatic duct or its branches: study using drip-infusion cholangiography-computed tomography in 179 consecutive patients.

Authors:  Masahiro Kitami; Gen Murakami; Saiho Ko; Kei Takase; Masahiro Tuboi; Haruo Saito; Yoshiyuki Nakajima; Shoki Takahashi
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

10.  Surgical treatment of hilar bile duct carcinoma: experience with 25 consecutive hepatectomies.

Authors:  Yoshifumi Kawarada; Bidhan C Das; Tatsushi Naganuma; Masami Tabata; Hiroki Taoka
Journal:  J Gastrointest Surg       Date:  2002 Jul-Aug       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.